SOLQIXRY Trademark

Trademark Overview


On Thursday, August 25, 2022, a trademark application was filed for SOLQIXRY with the United States Patent and Trademark Office. The USPTO has given the SOLQIXRY trademark a serial number of 79351830. The federal status of this trademark filing is REGISTERED as of Tuesday, March 19, 2024. This trademark is owned by NOVARTIS AG. The SOLQIXRY trademark is filed in the Pharmaceutical Products category with the following description:

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the p...
solqixry

General Information


Serial Number79351830
Word MarkSOLQIXRY
Filing DateThursday, August 25, 2022
Status700 - REGISTERED
Status DateTuesday, March 19, 2024
Registration Number7330144
Registration DateTuesday, March 19, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 2, 2024

Trademark Statements


Goods and ServicesAnti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, October 17, 2022
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameNOVARTIS AG
Party Type30 - Original Registrant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type20 - Owner at Publication
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Party NameNOVARTIS AG
Party Type10 - Original Applicant
Legal Entity Type25 - NOT AVAILABLE
AddressCH

Trademark Events


Event DateEvent Description
Friday, October 21, 2022APPLICATION FILING RECEIPT MAILED
Thursday, October 6, 2022SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, October 14, 2022LIMITATION FROM ORIGINAL APPLICATION ENTERED
Monday, October 17, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 3, 2022ASSIGNED TO EXAMINER
Monday, November 7, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, November 7, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, November 7, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, November 7, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Monday, November 7, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, November 7, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, November 7, 2022NON-FINAL ACTION WRITTEN
Tuesday, November 8, 2022NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Wednesday, January 18, 2023REFUSAL PROCESSED BY MPU
Wednesday, January 18, 2023NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Tuesday, November 21, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, February 7, 2023REFUSAL PROCESSED BY IB
Friday, June 16, 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, November 20, 2023ASSIGNED TO LIE
Tuesday, November 21, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, November 27, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 13, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, December 13, 2023NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, December 13, 2023NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, January 2, 2024PUBLISHED FOR OPPOSITION
Tuesday, January 2, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, March 6, 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Tuesday, March 19, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, March 19, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, March 26, 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Tuesday, January 2, 2024NOTIFICATION PROCESSED BY IB
Wednesday, March 6, 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Thursday, June 20, 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB